arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

PALATIN TECHNOLOGIES INC

PTN
$5.59 ▼ -0.21 (-3.53%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

PALATIN TECHNOLOGIES INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $15.8M
Dividend Yield —
Revenue Growth None
Op. Margin -65.7%
ROIC -102.4% ↘
FCF / Share $-4.80 ↗
Trailing P/E —
Price / Book 1.5x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.19M
↑ +193.6% —
Net Income Profit after all expenses
$-8.38M
↑ +51.6% —
Operating Margin Operating profit as % of sales
-65.7%
↓ -210.9% 1th
FCF / Share Free cash flow per share
$-4.80
↑ +87.9% —
Long-Term Debt Long-term obligations
$332.90K
— 0.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
1
Returns
5
Financial Health →
5
Cash Quality ↑
82

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 66 quarters